Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

Published Date: 11 Mar 2024

Whether or not patients also received chemotherapy, retrospective analysis reveals comparable OS and PFS.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Watch for Psoriasis After Cancer Immunotherapy, Study Says

2.

AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence

3.

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

4.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

5.

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot